Received: from 127.0.0.1 by
atlas-production.v2-mail-prod1-gq1.omega.yahoo.com pod-id
atlas--production-gq1-64b6454744-d4lkq.gq1.yahoo.com with https; Tue, 28 May
2024 21:53:55 +0000
Return-Path: <erosales@pharmafrigo.com>
X-Originating-Ip: [40.107.101.126]
Received-SPF: pass (domain of pharmafrigo.com designates 40.107.101.126 as
permitted sender)
Authentication-Results: atlas-production.v2-mail-prod1-gq1.omega.yahoo.com;
dkim=unknown;
spf=pass smtp.mailfrom=pharmafrigo.com;
dmarc=pass(p=NONE) Quelltext.from=pharmafrigo.com;
X-Apparently-To: xxx; Tue, 28 May 2024 21:53:56 +0000
X-YMailISG: KZxOM2IWLDsHNsF3DSfljApR0oH2g1mQFRm73g_7MnVmfdiZ
coLhdj7OAecfZOYOaoYgaXBU.iaQgTYKQt63js892HACOjMEf3V3dHhXExfK
T9.lxbzRczBYtDOB2eM.tuLFlArk9LYaz7rqoDY8x2RtMSMjX4UAriwDvlXy
ErGRdAXtiPCnYKx47gwOYxzzHtRbe88bXIGgdsbp9JMINmygufpPIYxGyLzA
0oqNKnLo_bEaP6Cilmq3UjRRA6OZ5Tfphp8A.6eKcJDNFy6LVYodOYVN9wgS
y.iGeXLxDwyuCpiq0_s6IgAm6hRrdEdNZ3QYpHX6K4_LuONsOL9GUjSLUCuD
PAngj8duRLr0IPCcIx_8yTA93w2bVXxsVGsC0fq9vXKEcrCbHssIu08wfpSE
yOg5.LgcKHNzRyU7sshjSFQgNPMsXaHDngbkIDqIDUcOew9KobdIOnOlWSs9
p0n0r_hflBQe8SedNX7WTydoKe7H4jOiplVNN5TS99FhKPnc11hG0lPT7knC
iml9QfVGfhaJ8DMZyjLuA0EpHWKMXwXER7eL8YRSbl2rp4OG4goafUOY4_NB
igsco2hsOtU3uu0DY4yfpbRaAxwgMfIV0HyEdzOzOUyjPGZvc5Az_tGvnbSp
ApeE9ulKBB4fgnZaeUQIWISkGvhoYpRsJc9QNrHDumZ5ynjZ0SnbdcsrM0kB
OoJyXlZnh10.4Mzz9Wiz4kw9fJvtphLKm.qHAFrKEA7rvxkQ9U7xhmiltaWG
serTAWBBkuletSjMjVJhLdQXzwgYRYItOPkONRanx8Bj67qTeHcbuzAWmtMy
vp_beLlU9Y2KVNjkqQyZyTGX5trMnlQZ.3QY9Njq.I8NXpSwYPq9SHzEfFgj
eWvB0k1DzZCYZNgOnuxSFNbbgbuujuceOBPfsJTOMYLfNYo7bOsqOAKiVRSF
SmsCWc7stywFr2fpQGFTIFkcHEtgqnJqgXr0fpPH57Rbe47RF6TtksZ3ci4.
2GRjPf1owjM4ilyXa21tx8CEjCG93JB3PUKvsJTJX9jHPCoGucCFX9vImWl1
3oC.2ExYty6QHOs6mtEIOJeV3dzUO3Q__916hfJ8GmBGUsiMrT04_Ybnt3P_
BfDA3hIY2.QYkWCoiugra9mPwWqYtNDFmV8LBfCv1X0UjiSsKvCQdNBLTxZH
FwSJ6K5_.wh91lcNHGL0_xEzOpk764XJulMOxaG1C9E8RHf46M_03g2C7vzV
mSJPXF2nlycxgySYH06SeczJurPo_O1U.yFM2n6NjDgwV1u_ebrBnUbRHQfc
hd8ur9ttNGi0PGf.gt_LQ6qdkwyIihsD3b6UBRzwxIeS8gn7lVFj7aczIh.4
EC2zKWDm5Q--
Received: from 40.107.101.126 (EHLO
NAM04-MW2-obe.outbound.protection.outlook.com) by 10.253.31.89 with SMTPs
(version=TLS1_2 cipher=TLS_ECDHE_RSA_WITH_AES_128_GCM_SHA256); Tue, 28 May
2024 21:53:55 +0000
ARC-Seal: i=1; a=rsa-sha256; s=arcselector9901; d=microsoft.com; cv=none;
vkPF1bkoBWloVj3dDbfykbvQ==
ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed;
d=microsoft.com; s=arcselector9901;
am-MessageData-1;
bh=yDl7M/2Kpay4xhGy9ISlmto65AgxyNSZASA5ZZ5XuVw=;
C3DPiZPD6MgNXeXbKQmgt4Xw==
ARC-Authentication-Results: i=1; mx.microsoft.com 1; spf=pass
smtp.mailfrom=pharmafrigo.com; dmarc=pass action=none
Quelltext.from=pharmafrigo.com; dkim=pass Quelltext.d=pharmafrigo.com; arc=none
Received: from BL3PR16MB4444.namprd16.prod.outlook.com
(2603:10b6:208:343::21) by DM4PR16MB5342.namprd16.prod.outlook.com
(2603:10b6:8:18b::5) with Microsoft SMTP Server (version=TLS1_2,
cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.7611.30; Tue, 28 May
2024 21:53:54 +0000
Received: from BL3PR16MB4444.namprd16.prod.outlook.com
([fe80::7023:bd6a:d059:8a3c]) by BL3PR16MB4444.namprd16.prod.outlook.com
([fe80::7023:bd6a:d059:8a3c%4]) with mapi id 15.20.7611.030; Tue, 28 May
2024 21:53:54 +0000
Message-ID: <8c3465e91dd9f3f8db763f9460a49de6c54b1bebf6@pharmafrigo.com>
Reply-To: Anastasiiaa <best.wickdeepshikha@gmail.com>
From: Anastasiiaa <erosales@pharmafrigo.com>
Subject: i dream every night
Date: Tue, 28 May 2024 23:53:53 +0200
Content-Type: multipart/mixed; boundary="89236ac135f1dcd7f45e17af2befe1c80ee7"
To: Undisclosed recipients:;
X-ClientProxiedBy: CH2PR05CA0051.namprd05.prod.outlook.com
(2603:10b6:610:38::28) To BL3PR16MB4444.namprd16.prod.outlook.com
(2603:10b6:208:343::21)
MIME-Version: 1.0
X-MS-PublicTrafficType: Email
X-MS-TrafficTypeDiagnostic: BL3PR16MB4444:EE_|DM4PR16MB5342:EE_
X-MS-Office365-Filtering-Correlation-Id:
08f7d90e-0586-4dc2-be9c-08dc7f60ab42
X-MS-Exchange-SenderADCheck: 1
X-MS-Exchange-AntiSpam-Relay: 0
X-Microsoft-Antispam:
     BCL:0;ARA:13230031|1800799015|52116005|366007|376005|38350700005;
X-Microsoft-Antispam-Message-Info:
     =?utf-8?B?eG50VlNlTE9GbFgzR0dtbGFwWW1nRnBDNS9lcUJBOWEvOURPS3kzMkkxUDhT?=
=?utf-8?B?WXpJaGR3bGc4YXpxZWU4ZFAxSk1Ia3NoZ3k5SEk3dE1QNnBlc2FZN2lHVXk5?=
=?utf-8?B?QVRTNlo2ZzlZdGtuT2lWK1o2VFd5OW5OV0hPRkhzQmpZVExMRWNMTmVYSmxQ?=
=?utf-8?B?TGozNHJuSlJBc2xrcDl4c3AyUllqQVZ0TWNTd3VvclBRN2J2NUlrU2Zzc3Bz?=
=?utf-8?B?aGlSbEF6cDhuNjdpT1JVL1pBbkh0NlVNcURZSXFISnRDMDhYQW8xVHFkTzZr?=
=?utf-8?B?L1d0dzhXbkoxWHF4SE9qUEtYRXhiNzVrMjAreGYyRGNEd3ZKeDlaV2ZUUlhQ?=
=?utf-8?B?aUZLaWRCN01lWlNGTTU1ZXNhdDgwd1I5UzI3Nk90cDQyMU1KT3pOSC9vR1Z2?=
=?utf-8?B?bFh6MWdGNHJZeXVzcTJRLzB0ZW9HblAxRXY5RUxQY0FobjNjcXEybGVEOUhJ?=
=?utf-8?B?UUdMYUJpUEk4WVVDTmR1cGtnRUNQWGM4OHE1QzlNM1J3YURiVENKVXRMLy94?=
=?utf-8?B?OHJ3dUtNYU0zRE1RSXFod2kwQTlpcjI1OTJ1bjcwRTdoUEVqSnEzVEJlQS9l?=
=?utf-8?B?YmY2WlRVR0NKSzVuS1k1VFR3c2ZuTTVYRFRqT2ZrZVFXdlRmeE1FcXhPeTZV?=
=?utf-8?B?dThJbG15UXdCYndDYkpHRC9YSk9xYytFZ0JQdjZKTmJvWnhrbGxuN2VVNE5a?=
=?utf-8?B?ZWpYWE1kN2hCMjI3RHExQVdkdjFBVGVZa29RdjVsMkJidlRQUE5CSVhnUS9w?=
=?utf-8?B?dnc5RForb05PendTTGxqR0ZyY3Z2N282bUIvTGFLdXVrK2V3ZzNRNC9IYkMr?=
=?utf-8?B?aGhEeDZTZkxJSzMyaTZNQlhCRFRCRFlZaldBMW5pTkQxbUp3bXpOTHAwcmxS?=
=?utf-8?B?SS84eGo2Um9PclBKd29FUnYvVHAvTVphOUJPWkhWbDRBZlFzYTZLcXM5d0o4?=
=?utf-8?B?UG1Za1NWamxVK2dBYzN1VmNvdkwzRjVSc1ZaTDVCU1RTYmgxNnhXMlNJMHhl?=
=?utf-8?B?anJSRGdBdUJad2pjOEJTZkhVaytHRys1SjBzcEdIQzEzamVVS2Z1aDZBdXVH?=
=?utf-8?B?WTBkRlY0WlVaSEpnOVkvUkZOVXRrY2pHeWJibTZiUEI3UzlobDM2R3Y4bHFL?=
=?utf-8?B?WndsUzl5aW41UUkzanZod1liejJYOHJDeDBrYVVqMkVKRnlqN1NJdGxqZ3Bq?=
=?utf-8?B?QlhTUWp5U2NyN3RnVnZzNGcreS9heVVwdHRRZGZHTGlPR3N4WGhkTW4wWUN1?=
=?utf-8?B?REFTekZleTZGck9MenhVSVkxWC9Qb2NNbytuMG40SXJJcG0xbGVDV1JoY2VH?=
=?utf-8?B?VDlnM1ZDbXJuMHlQem5ucDlQblVyM2dwL1R1akpuRkNldzN4TGdhQlA5WXgr?=
=?utf-8?B?SGx2TWxSV0NEanE5eUhhV1pKVXFVT0FodC8wZ2w4N0ZtN3ZUdUxQQjVZNmRz?=
=?utf-8?B?bktlbTE3VUdkVUl0cXFOWDJFeElxTGFDVnEva1prUFZVZW5oTXFIcXdhbTR4?=
=?utf-8?B?cGtvN010a2tPV0xTTnVieHpndkxOR2JodUIzdE1jNjRlSDVyNW8xSWtmeVNa?=
=?utf-8?B?VWNGQ212QmpDWUdpU0d5ZWdXZFZKaUZLQnV5T1RjUml1K3d1b0RLWC9Vc1Ns?=
=?utf-8?B?TTNRdmpSSVZxYitWelJ5UUdXYmpPbW9zb0tDMTNEZWdibHEySXlLT096a1lN?=
=?utf-8?B?dGxzNUpCWVFIT0Y0bEI0UUFJdzhuaks5VTNEUnR4WUlwSWFTT1hsSHBKeGpi?=
=?utf-8?B?Vlk3WjNJSHNVOG9JdGE2dWlOOGFwZ3JJOUdkdHRpUC82ci9FaHFDdWlmb1Ix?=
=?utf-8?B?Z2xjaVdjb3ZuUEJTZHJzUT09?=
X-Forefront-Antispam-Report:
7)(376005)(38350700005)IR:OUT;SFP:1102;
X-MS-Exchange-AntiSpam-MessageData-ChunkCount: 1
X-MS-Exchange-AntiSpam-MessageData-0:
     =?utf-8?B?TVo0OTkxNjdUaE52N0JnVXNrWkZZeWtROWIrL0t1emNOblVGWm5MVXBJaWxG?=
=?utf-8?B?RkNONDdmcWtYQnpMV0FGaUd1bnFhK2U5RUFRYVNKK3hrK1YyM25pWmI5L2Vh?=
=?utf-8?B?WEV0eWJTMmd5MTdWWFJsYzJJQWQ4RnFkUE5IYjJzdGdJNWhYSUxad3QwcE9a?=
=?utf-8?B?cDQwQnJ3UDNhNW1xdlJBV3RmTmlISlFHdkJUR1VncUlBZ1FES2p2aXBZeUQy?=
=?utf-8?B?VHE3UEhlUWpuR0JWdGlBa3V2bytVc21lV1d1RVNVK01rTFR1NGhRMWdheFRM?=
=?utf-8?B?eGtJSE1iUTNaSnZBRjFYbXNlR0JyaEJzd29YUFdYODFZRW5YSzNLRUt2b1gx?=
=?utf-8?B?Z2pWWlJlc2JTM3BTeVhOM2VSK2JMTUY1VHZsV2IzQzJSbWlEWkVSVTNHdHpS?=
=?utf-8?B?WGpISW1qZFZhRUdLb2t5TXlhc3dPYVhpNzZBU1cvSzgydjBOVUNTWHdtWXZy?=
=?utf-8?B?a2cvb0pHNVZwSWRHQjhINjFpcU1ySGRLaHRIOEpleXVCKzFtUTdrcTdPNEtY?=
=?utf-8?B?NTloRUdQSWkxSHdCdmY4T21wRlk2WlBFRmJRb1dhTm02cEkxVXhKZkltUmhF?=
=?utf-8?B?QzZ0WFJ3WG1Sb05VTnZjL3h0U2hTR1RtVmJNTmM0cFZDQ09hSXFtS2dGWFMz?=
=?utf-8?B?WldkT21hUTZSZFpjQ3FOMk9naXd3SGZ4S3M4emlLZU9xNjhmWmd6STRoSHNG?=
=?utf-8?B?V1RYMmdob3RqNmtabmtUOVRRS3RQcyt5cFVjdGJQNUo4MzRnajZFT1hlWThP?=
=?utf-8?B?RUpyUTV3Z3NHNHg3dUYyR2pzVXdwckhlYWRpUEp1TTlJM1pab1pkQnludmc2?=
=?utf-8?B?TGhNR1pVVlU0WFJHTnRWWkFtUjhiNW91c1pPZzdWdWZocElUUjRrNGtVWWVa?=
=?utf-8?B?dy9hSWg0TFdrRExWS0k5aDVjc0QvVS9hSGlGcmd6d3NleUVXOHVRcExKMGxM?=
=?utf-8?B?d0ZUV1lZM05zVGRuMHZnM0grMGZ4THgwcHEydW5leEFENFN0VFp1ZHlOL2NJ?=
=?utf-8?B?b2FvMnprRENCZytNcFZjRzVkR2phditrZ0cza1BsRDYwUU9Lc3VrclZhcUlS?=
=?utf-8?B?ZjRUL3hBbFV3QnE1aWYrQlZWOFhReFN5M3VYeEQyeU1NMCtrL002dGpLbXlH?=
=?utf-8?B?TkZVZ3FJMjg4YkNRVWtDNWtvREM1RzBIM3pQeml5MEx5M2FvNmF5TG1pVEd2?=
=?utf-8?B?ZGdOWW52QitOUnFTMlVuZE03SmV4VXF3SXBqdXhuakQyZXZURkcxalp2RTRh?=
=?utf-8?B?Zk5MOG8vZzJ5K2RKYW1SWTRtbVJHUDc4Wkt1SEtzWmpQWml5ekNMZjdKNDln?=
=?utf-8?B?aXlITWtVYjA3eDRTYWE3aUpoa0JDM0o4ay9zTkN6RlNIYVBHN0VmbWtjYWdz?=
=?utf-8?B?cENIcEhjN1ZNMnM0bGZ2M21peFJQZGVZV2Q0bk0yckp0M21UMERzKzFNbktv?=
=?utf-8?B?OGlDTGF1Nm5neDJDeDJlQjNlZWtZVU1wQkNSQ0tGWWJCU2EyQTdwUGIvVlhY?=
=?utf-8?B?SHVvVG4zd29QZ3ZJeENiMnpEaUtabjBzbmlCMWhTQjYxdUhOSlBoRTdBWkZT?=
=?utf-8?B?QnQ1Y1RLK0VrUUE0aFgvTDhWV0JTUnRFTDJraWlTZjQvZFRXUXp0NFF6aG9h?=
=?utf-8?B?S1lVRVhYSXpMODFvK21QOEtVYzROMFV4ZVlRc3V1ampVOUhjZEpici8rRTYx?=
=?utf-8?B?ZGc0NlhOY1RvYWJUc0xDbnJtSWVQWWhwRkRpWHJBd2NlUGdrOTgvbUl4NXVl?=
=?utf-8?B?ZVlkV3JTTVJVQnptbE5MZDY3ZHhmbjgrQXE1SzBYRjk0K3I5ZTB5bm9pRktm?=
=?utf-8?B?b2xoV1RsUW1za1NPS2E4MzMwVndWOW82bkpPcWNsYU9IMjJxV0w1cVZIYVBR?=
=?utf-8?B?SENMOHcyK2ZRaUdhL0Z0QStubnBvYk8wRVlhVnE1S2pJbEwwQkg5OTR3dDdN?=
=?utf-8?B?UE5lNVdaR1dXcUh0SG9oeG03NnVUQ2xaYk5XVE1rSVBobjc3bExzcUsrSFBY?=
=?utf-8?B?bXo3VktQclFlbU5OZFdRUE5IUnRxeldzbGpKalVac1g3UFJZSGZPR2hYTkhw?=
=?utf-8?B?SXpNeDBYOG81bkRsTHNyNDZVR0NYQ0Z3TkU4d2dhMkpPS3J1ZXlwMDMxWEFP?=
=?utf-8?B?ZlZsL1R3VTR1N1FvY0VjWTdKWkUxK1p2Ylo1dEpqMzVYVXoxT2NPSXEzTm9K?=
=?utf-8?B?N0E9PQ==?=
X-OriginatorOrg: pharmafrigo.com
X-MS-Exchange-CrossTenant-Network-Message-Id:
08f7d90e-0586-4dc2-be9c-08dc7f60ab42
X-MS-Exchange-CrossTenant-AuthSource:
BL3PR16MB4444.namprd16.prod.outlook.com
X-MS-Exchange-CrossTenant-AuthAs: Internal
X-MS-Exchange-CrossTenant-OriginalArrivalTime: 28 May 2024 21:53:54.7751
(UTC)
X-MS-Exchange-CrossTenant-FromEntityHeader: Hosted
X-MS-Exchange-CrossTenant-Id: 101e9d50-4efa-4d91-b344-e9dfd130b50c
X-MS-Exchange-CrossTenant-MailboxType: HOSTED
X-MS-Exchange-CrossTenant-UserPrincipalName:
OFaeO4xz6DQhGYABxHQXO6SyfJU=
X-MS-Exchange-Transport-CrossTenantHeadersStamped: DM4PR16MB5342
Content-Length: 52590
X-Evolution-Source: 0a4e02f15473e5963fd4a73df705cd5f18106aa4